LumiraDx LtdOTC Pink - Current Information:LMDXF
- LAST PRICE0.0170
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.0136/ 100
- Ask / Lots0.0200/ 100
- Open / Previous Close0.0000 / 0.0170
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | LMDXF |
|---|---|---|
| 09:38 ET | 10000 | 0.0141 |
| 09:41 ET | 14380 | 0.0153 |
| 09:54 ET | 11000 | 0.0153 |
| 09:59 ET | 3173 | 0.01478 |
| 10:08 ET | 6800 | 0.0153 |
| 10:10 ET | 1000 | 0.0141 |
| 10:33 ET | 400 | 0.0141 |
| 11:04 ET | 500 | 0.0153 |
| 11:13 ET | 3800 | 0.0141 |
| 11:49 ET | 400 | 0.0153 |
| 12:05 ET | 243594 | 0.0131 |
| 12:21 ET | 50000 | 0.014 |
| 12:36 ET | 385 | 0.0141 |
| 12:41 ET | 100 | 0.0147 |
| 12:56 ET | 38146 | 0.0153 |
| 12:57 ET | 400 | 0.0147 |
| 01:01 ET | 3151 | 0.0153 |
| 01:03 ET | 76600 | 0.016 |
| 01:06 ET | 90065 | 0.017 |
| 01:19 ET | 1000 | 0.02 |
| 01:42 ET | 900 | 0.016 |
| 02:22 ET | 100 | 0.0172 |
| 02:47 ET | 4120 | 0.016 |
| 02:54 ET | 39980 | 0.016 |
| 03:50 ET | 10000 | 0.02 |
| 03:54 ET | 97404 | 0.02 |
| 03:57 ET | 1000 | 0.017 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
LumiraDx Ltd | 2.8M | 0.0x | --- |
Cutera Inc | 42.3M | -0.3x | --- |
TruBridge Inc | 117.8M | -2.6x | --- |
Pacific Biosciences of California Inc | 393.9M | -1.2x | --- |
Zynex Inc | 357.9M | 41.9x | +1.09% |
Outset Medical Inc | 124.1M | -0.7x | --- |
Company Information
LumiraDx Limited is a point of care diagnostic company. The Company is focused on transforming community-based healthcare by providing critical diagnostic information to healthcare providers at the point of need. The Company has developed and launched the LumiraDx Platform, which is an integrated system comprised of a small, versatile Instrument, low-cost microfluidic Test Strips, and seamless, secure digital connectivity. The Company offers a menu of lab comparable tests on a single portable platform, with more than 30 assays on the market and in various stages of development, covering infectious diseases, cardiovascular diseases, diabetes, and coagulation disorders. It also supports laboratory testing in an accessible high-throughput format to leverage molecular laboratory operations. Its diagnostic testing solutions are being deployed globally by governments and healthcare institutions across laboratories, urgent care, physician offices, pharmacies, schools and others.
Contact Information
- Headquarters
- Windward 3, Regatta Office PO Box 1350GRAND CAYMAN, Cayman Islands KY1-1108
- Phone
- 178-643-0411
- Fax
- ---
Executives
- President - North American Commercial Operations
- Peter Scheu
- Deputy Chief Executive Officer, General Counsel
- Veronique Ameye
- Chief Financial Officer, Vice President, Global Operations
- Dorian LeBlanc
- Senior Vice President - Instrumentation & Health IT
- Thomas Quinlan
- Chief Innovation Officer
- Nigel Lindner
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.8M |
|---|---|
Revenue (TTM) | $126.5M |
Shares Outstanding | 164.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.08 |
Book Value | $-0.64 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -241.22% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
